These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29904452)

  • 1. Revisiting the Role of Antiarrhythmic Drugs in Prevention of Atrial Fibrillation Recurrence: A Single Center Retrospective Review.
    Mascarenhas DA; Sharma M
    Cardiol Res; 2018 Jun; 9(3):165-170. PubMed ID: 29904452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
    Guerra F; Hohnloser SH; Kowey PR; Crijns HJ; Aliot EM; Radzik D; Roy D; Connolly S; Capucci A
    Clin Cardiol; 2014 Dec; 37(12):717-24. PubMed ID: 25470298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation.
    Waks JW; Zimetbaum P
    J Cardiovasc Pharmacol Ther; 2017 Jan; 22(1):3-19. PubMed ID: 27260643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
    Gulizia M; Mangiameli S; Chiarandà G; Spadola V; Di Giovanni N; Colletti A; Bulla V; Circo A; Pensabene O; Vasquez L; Vaccaro I; Grammatico A;
    Europace; 2006 Apr; 8(4):302-5. PubMed ID: 16627459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of medical treatment on long-term results after surgical ablation of atrial fibrillation in cardiac surgical patients.
    Feyrer R; Ballazhi F; Seitz T; Weyand M; Harig F
    Ann Thorac Cardiovasc Surg; 2014; 20(3):207-12. PubMed ID: 23558224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient Initiation of Sotalol in Patients with Atrial Fibrillation: Utility of Cardiac Implantable Electronic Devices for Therapy Monitoring.
    Mascarenhas DAN; Mudumbi PC; Kantharia BK
    Am J Cardiovasc Drugs; 2021 Nov; 21(6):693-700. PubMed ID: 34291437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.
    Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
    Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):292-300. PubMed ID: 25829248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.
    Xu X; Alida CT; Yu B
    Cardiovasc Ther; 2015 Aug; 33(4):242-6. PubMed ID: 26031448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis.
    Kim MH; Smith PJ; Jhaveri M; Lin J; Klingman D
    Clin Ther; 2011 Nov; 33(11):1668-1681.e1. PubMed ID: 22108302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.
    Camm J
    Int J Cardiol; 2012 Mar; 155(3):362-71. PubMed ID: 21708411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
    Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S
    J Cardiol; 2016 May; 67(5):471-6. PubMed ID: 26233885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation.
    Igarashi M; Tada H; Sekiguchi Y; Yamasaki H; Arimoto T; Kuroki K; Machino T; Murakoshi N; Aonuma K
    Am J Cardiol; 2010 Jul; 106(1):62-8. PubMed ID: 20609649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian network meta-analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillation.
    Elsayed M; Abdelfattah OM; Sayed A; Prasad RM; Barakat AF; Elgendy IY; Andrade J; Jared Bunch T; Thosani A; Saliba WI; Wazni OM; Hussein AA
    J Cardiovasc Electrophysiol; 2022 Feb; 33(2):197-208. PubMed ID: 34855270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Cardioversion after Pre-Treatment with Antiarrythmic Drugs Prior to Electrical Cardioversion in Persistent Atrial Fibrillation: Impact on Maintenance of Sinus Rhythm.
    El Amrani A; Viñolas X; Arias MA; Bazan V; Valdovinos P; Alegret JM
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33802253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations between baseline burden, maximum duration, and relative reduction of atrial fibrillation: Insights from continuous monitoring in rhythm control.
    Lin PL; Huang CC; Wu YJ; Su MI; Chiou WR; Liu LY; Liao FC; Lai E; Chen CY; Kuo JY; Lee YH
    J Cardiovasc Electrophysiol; 2019 Feb; 30(2):178-182. PubMed ID: 30575199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study.
    Kosior DA; Opolski G; Wozakowska-Kaplon B; Rabczenko D;
    Cardiology; 2005; 104(1):35-44. PubMed ID: 15942183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.